Showing 1 - 1 of 1 results
Status:
Other
Class (Stereo):
CHEMICAL (RACEMIC)
Targets:
PK-11195 was first discovered by Pharmuka Laboratories. It was found to be antagonist of the Translocator Protein (TSPO) with potential for development in a number of conditions including cancer models, cardiac ischemia, seizures, depression, and anx...